Table 1.
Plasma epinephrine, norepinephrine, and glucagon concentrations on d 2 studies in the control (C and C+), N+, and N− studies at basal (time 0), peak, and their respective glycemic thresholds
| C | C+ | N+ | N− | |
|---|---|---|---|---|
| Epinephrine | ||||
| Basal (pg/ml) | 38 ± 15 | 34 ± 18 | 37 ± 14 | 35 ± 12 |
| Peak (pg/ml) | 810 ± 94 | 765 ± 110 | 852 ± 82 | 374 ± 71a |
| Glycemic threshold (mg/dl) | 73 ± 7 | 71 ± 5 | 75 ± 4 | 63 ± 6a |
| Norepinephrine | ||||
| Basal (pg/ml) | 196 ± 42 | 174 ± 29 | 180 ± 33 | 170 ± 32 |
| Peak (pg/ml) | 686 ± 98 | 719 ± 83 | 769 ± 77 | 307 ± 65a |
| Glycemic threshold (mg/dl) | 71 ± 4 | 69 ± 5 | 69 ± 5 | 62 ± 4a |
| Glucagon | ||||
| Basal (pg/ml) | 45 ± 5 | 41 ± 6 | 47 ± 3 | 46 ± 4 |
| Peak (pg/ml) | 93 ± 4 | 89 ± 5 | 98 ± 7 | 71 ± 9a |
| Glycemic threshold (mg/dl) | 68 ± 4 | 70 ± 3 | 68 ± 4 | 65 ± 3a |
a
P < 0.05 vs. C, C+, and N+.